TheScreener - Nu Skin Enterprises Inc. Class A (NUS) For NU SKIN ENTERPRISES, the environment deterioration entails a downgrade to Neutral

Report

TheScreener

EUR 14.08 For Business Accounts Only

For NU SKIN ENTERPRISES, the environment deterioration entails a downgrade to Neutral

NU SKIN ENTERPRISES (US), a company active in the Personal Products & Services industry, now shows a lower overall rating. The independent financial analyst theScreener just confirmed the fundamental rating of 3 stars out of 4, as well as the stock market behaviour of the title as moderately risky. However, environmental deterioration penalises the general evaluation, which is downgraded to Neutral. As of the analysis date November 30, 2021, the closing price was USD 43.88 and its expected value was estimated at USD 43.97.

01/12/2021 1 EN

Underlying

Nu Skin Enterprises Inc. Class A

Nu Skin Enterprises develops and distributes a line of beauty and wellness solutions. The company's primary product categories are personal care products and wellness products. The company develops and distributes products in these two categories under its Nu Skin and Pharmanex brands, respectively. The company's personal care products include its skin care devices. The company's skin care devices and related consumables are ageLOC Spa systems and its ageLOC LumiSpa skin treatment and cleansing device. The company's wellness products line includes its LifePak nutritional supplements, ageLOC Youth nutritional supplements and its ageLOC TR90 weight management and body shaping system.

See profile

US67018T1051 New York Stock Exchange United States

Provider

TheScreener

Empowering Investors

theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.

Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization. theScreener state of art: We provide
theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded.

See profile

Other Reports on these Companies

SmartInsider

Nu Skin Enterprises Inc: 1 director

A director at Nu Skin Enterprises Inc sold 15,400 shares at 17.680USD and the significance rating of the trade was 56/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names...

Free Trial

November 7, 2023 November 7, 2023 1 EN

GlobeNewsWire

Nu Skin Enterprises to Announce Second Quarter 2023 Financial Results

Nu Skin Enterprises to Announce Second Quarter 2023 Financial Results PROVO, Utah, July 10, 2023 (GLOBE NEWSWIRE) -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will release second quarter 2023 results after the market closes on Tuesday, Aug. 1. The Nu Skin management team will host a conference call with the investment community later that same day at 5 p.m. ET. During the call, management will discuss recent results and upcoming business initiatives. The webcast of the conference call, including the financial information presented, will be available on the investor relatio...

July 10, 2023 July 10, 2023 1 EN

GlobeNewsWire

Nu Skin Celebrates 20th Annual Force for Good Day with Global Day of Service

Nu Skin Celebrates 20th Annual Force for Good Day with Global Day of Service The company continues its commitment to help children worldwide with hospital kits and hygiene products, as well as a donation to Primary Children’s Hospital in Utah County from its nonprofit foundation PROVO, Utah, June 07, 2023 (GLOBE NEWSWIRE) -- Today, Nu Skin is hosting its 20th annual Force for Good Day to support its global humanitarian efforts. To celebrate the company’s founding and to give back to local communities, each Nu Skin region sets aside a day to participate in service projects as part of th...

June 7, 2023 June 7, 2023 1 EN

AC ENERGY CORP increases its risk exposure and slightly lowers to Neutral

AC ENERGY CORP (PH), a company active in the Alternative Electricity industry, now shows a lower overall rating. The independent financial analyst theScreener confirms the fundamental rating of 4 out of 4 stars. However, the market behaviour deterioration triggered a risk requalification, which can be thus described as moderately risky. theScreener believes that increased risk justifies the general evaluation downgrade to Neutral. As of the analysis date April 8, 2022, the closing price was PHP 8.54 and its expected value was estimated at PHP 8.53.

Free Trial

April 9, 2022 April 9, 2022 1 EN

With a more favourable environment, VUKILE PROPERTY improves to Positive

VUKILE PROPERTY (ZA), a company active in the Real Estate Holding & Development industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 4 out of 4 stars, as well as its unchanged, defensive market behaviour. The title leverages a more favourable environment and raises its general evaluation to Positive. As of the analysis date April 5, 2022, the closing price was ZAR 13.72 and its potential was estimated at ZAR 15.16.

Free Trial

April 6, 2022 April 6, 2022 1 EN

An unfavourable environment weighs on ROYAL BAFOKENG PLATINUM, which sees a downgrade to Slightly Negative

The independent financial analyst theScreener just requalified the general evaluation of ROYAL BAFOKENG PLATINUM (ZA), active in the Platinum & Precious Metals industry. As regards its fundamental valuation, the title still shows 0 out of 4 stars and its market behaviour is seen as moderately risky. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Slightly Negative. As of the analysis date April 5, 2022, the closing price was ZAR 159.78 and its target price was estimated at ZAR 127.50.

Free Trial

April 6, 2022 April 6, 2022 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

For NU SKIN ENTERPRISES, the environment deterioration entails a downgrade to Neutral

Empowering Investors

Nu Skin Enterprises Inc: 1 director

Nu Skin Enterprises to Announce Second Quarter 2023 Financial Results

Nu Skin Celebrates 20th Annual Force for Good Day with Global Day of Service

AC ENERGY CORP increases its risk exposure and slightly lowers to Neutral

With a more favourable environment, VUKILE PROPERTY improves to Positive

An unfavourable environment weighs on ROYAL BAFOKENG PLATINUM, which sees a downgrade to Slightly Negative

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe